Our study provides the first evidence for the interaction of lncRNA H19, p53, and TNFPI8 in breast cancer cell progression and metastases, highlighting the promising therapeutic potential of this axis for treatment of breast cancer. This evidence concerns the gene H19 and breast carcinoma.